Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

187 results
Display

Unmasked Obstructive Hypertrophic Cardiomyopathy after Mitral Valve Repair for Severe Mitral Regurgitation

Kim D, Shim CY, Hong GR, Chang BC

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A comprehensive review of hypertrophic cardiomyopathy and arterial thromboembolism in cats

Han D, Jung DI

The number of cats requiring treatment for hypertrophic cardiomyopathy (HCM) and arterial thromboembolism (ATE) continues to increase, and the knowledge regarding its management is constantly evolving. The pathological lesions of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prevalence, Characteristics, and Clinical Significance of Concomitant Cardiomyopathies in Subjects with Bicuspid Aortic Valves

Jeong H, Shim CY, Kim D, Choi JY, Choi KU, Lee SY, Hong GR, Ha JW

PURPOSE: The present study aimed to investigate the prevalence, characteristics, and clinical significance of concomitant specific cardiomyopathies in subjects with bicuspid aortic valves (BAVs). MATERIALS AND METHODS: A total of 1186...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sigmoid Septum and Aberrant Calcified Papillary Muscle in the Setting of Advanced Hypertrophic Cardiomyopathy: An Unusual Life-threatening Coalescence

Hallo C, Kottiech S, Castillo J

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recent Update of Advanced Imaging for Diagnosis of Cardiac Sarcoidosis: Based on the Findings of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography

Chang S, Lee WW, Chun EJ

Sarcoidosis is a multisystem disease characterized by noncaseating granulomas. Cardiac involvement is known to have poor prognosis because it can manifest as a serious condition such as the conduction abnormality,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical and molecular characterization of Korean children with infantile and late-onset Pompe disease: 10 years of experience with enzyme replacement therapy at a single center

Kim MS, Song A, Im M, Huh J, Kang IS, Song J, Yang A, Kim J, Kwon EK, Choi EJ, Han SJ, Park HD, Cho SY, Jin DK

PURPOSE: Pompe disease (PD) is an autosomal recessive disorder caused by a deficiency of acid alpha-glucosidase resulting from pathogenic GAA variants. This study describes the clinical features, genotypes, changes before...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Fabry Disease that Phenocopies Hypertrophic Cardiomyopathy: a thorough Genetic ‘Detective’ Identifies the ‘Rogue’ Hidden in the GLA Gene

Kwon S, Lee SP, Park SS, Kim BJ, Kim HK, Cho HJ, Seong MW, Sohn DW

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Biventricular Hypertrophic Cardiomyopathy with Severe Right Ventricular Outflow Track Obstruction

Lim DS, Lee CH

Hypertrophic cardiomyopathy (HCM) has diverse pathophysiological and clinical features, according to the extent and severity of the hypertrophy development. Hypertrophy mostly involves the left ventricle and sometimes causes a left...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Left Ventricular Noncompaction Associated with Hypertrophic Cardiomyopathy: Morphologic and Functional Evaluation with Multidetector CT

Lee H, Lee JW, Meinel FG, Schoepf UJ

Hypertrophic cardiomyopathy and left ventricular (LV) noncompaction are American Heart Association-recognized cardiomyopathies with distinct clinical and pathoanatomical features that are presumed to have different etiologies. We present two cases with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The association between T wave inversion and apical hypertrophic cardiomyopathy

Chae CB, Ha JH, Kim JH, Lee JJ, Choi HI, Park KB, Kim JH, Choi JH

OBJECTIVES: Electrocardiograhy (ECG) is the first step in hypertrophic cardiomyopathy (HCMP) diagnosis. For various reasons, the T wave inversion (TWI) and ECG change with time and HCMP is not easy...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Identification of LAMP2 mutations in early-onset hypertrophic cardiomyopathy by targeted exome sequencing

Gill I, Kim JH, Moon JH, Kim YJ, Kim NS

X-linked dominant mutations in lysosome-associated membrane protein 2 (LAMP2) gene have been shown to be the cause of Danon disease, which is a rare disease associated with clinical triad of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Growth hormone therapy in patients with Noonan syndrome

Seo GH, Yoo HW

Noonan syndrome (NS) is an autosomal dominant disorder that involves multiple organ systems, with short stature as the most common presentation (>70%). Possible mechanisms of short stature in NS include...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hypertrophic obstructive cardiomyopathy in a Yorkshire Terrier

Hwang T, Park J, Jung D, Lee HC

An 11-year-old, castrated male dog presented with a 3-month history of cough and depression. Auscultation revealed systolic murmur and thoracic radiographs showing enlargement of both the atrium and left ventricle....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
2018 KHRS Guidelines for Catheter Ablation of Ventricular Arrhythmias: Part 3

Cho Y, Kim SH, Kim YR, Kim YN, Kim JY, Kim TH, Nam GB, Roh SY, Park KM, Park HS, Pak HN, Bae EJ, Oh S, Yoon N, Lee MY, Cho Y, Jin ES, Cha TJ, Choi JI, Kim J

Treatment of ventricular arrhythmias (VA) usually involves managing the underlying cardiac conditions that cause the arrhythmia. However, managing the underlying disease is often challenging, and catheter ablation, or treatment targeting...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Tips for Successful Septal Myectomy in Patients with Hypertrophic Cardiomyopathy

Kim JH

Septal myectomy is the gold-standard treatment of hypertrophic cardiomyopathy. However, it involves the risk of incomplete resection of septal muscles or iatrogenic septal perforation depending on the surgeon's practice. Herein,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Severe chest pain with mid-ventricular obstruction in a patient with hyperthyroidism

Nam JH, Son JW, Hong GR

Mid-ventricular obstruction (MVO) rarely occurs in patients without hypertrophic cardiomyopathy. Increased cardiac contractility may play an important role in causing MVO. We experienced a case of severe chest pain and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of a Proteasome Inhibitor on Cardiomyocytes in a Pressure-Overload Hypertrophy Rat Model: An Animal Study

Kim IS, Jo WM

BACKGROUND: The ubiquitin-proteasome system (UPS) is an important pathway of proteolysis in pathologic hypertrophic cardiomyocytes. We hypothesize that MG132, a proteasome inhibitor, might prevent hypertrophic cardiomyopathy (CMP) by blocking the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cardiomyopathies with Mixed and Inapparent Morphological Features in Cardiac Troponin I3 Mutation

Sohn DW, Kim HK, Kim YJ, Oh S, Seong MW, Park SS

The fact that different types of cardiomyopathies can be manifested by the same sarcomere protein gene mutation in a single family is well known. However, mixed features of different types...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Diverse Phenotypic Expression of Cardiomyopathies in a Family with TNNI3 p.Arg145Trp Mutation

Hwang JW, Jang MA, Jang SY, Seo SH, Seong MW, Park SS, Ki CS, Kim DK

Genetic diagnosis of cardiomyopathies is challenging, due to the marked genetic and allelic heterogeneity and the lack of knowledge of the mutations that lead to clinical phenotypes. Here, we present...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
RE: Papillary Thyroid Carcinoma Treated with Radiofrequency Ablation in a Patient with Hypertrophic Cardiomyopathy: A Case Report

Kim EK

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr